European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment
Abstract
BACKGROUND: This first part of the S2k guidelines is an update of the 2015 S1 European guidelines based on the structured assessment of clinically relevant topics by the panel of experts. It is complemented by Part 2, which deals with treatments. OBJECTIVES: These guidelines aim to provide the generalist with expert guidance regarding clinically relevant topics such as, for example, diagnosis, clinimetrics and comorbidities. METHODS: The S2k level guidelines signify that they are based on expert consensus. This includes all the topics touched upon, all selected after a Delphi procedure among the experts/authors and edited into a coherent whole providing an overview of the subject. Certain passages have been adopted without changes from the previous version. The treatment of the disease and potential treatment complications are not included, being beyond the scope of this guidelines part. RESULTS: Since the S1 guidelines publication, the literature on HS management has grown rapidly, enabling the current revision. The expansion of the guideline is evident and signifies a major leap forward in HS management. CONCLUSIONS: The first part of the guideline for HS provides a consensus-based advice aimed at improving the health care of patients with HS at a generalist level through expert advice.
// Source
Authors: Gregor B. E. Jemec, Bente Villumsen, Kelsey R. van Straalen, Hessel H. van der Zee, Skaidra Valiukevičienė, T. Tzellos, J.C. Szepietowski, A. Szegedi, Ditte Marie Lindhardt Saunte, Marco Romanelli, H. Raynal, Francesca Prignano, E.P. Prens, M. Podda, A. Nassif, Alejandro Molina‐Leyva, Łukasz Matusiak, Angelo Valerio Marzano, Barry M. McGrath, Aikaterini Ι. Liakou, B. Kirby, L. Kemeny, E. Just, D. Ioannides, John R Ingram, RE Hunger, B. Horváth, Philippe Guillem, Øystein Grimstad, Evangelos J. Giamarellos‐Bourboulis, Mateja Dolenc‐Voljč, V. Del Marmol, Z. Bukvić Mokos, Vincenzo Bettoli, F. Benhadou, Falk G. Bechara, Christos C. Zouboulis
Institutions: University Medical Center Groningen, Cardiff University, University of Copenhagen, Lithuanian University of Health Sciences, Hospital of Lithuanian University of Health Sciences Kaunas Clinics, University of Szeged, University of Bern, AGH University of Krakow, Erasmus MC, University of Florence, Goethe University Frankfurt, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Wrocław University of Science and Technology, University Hospital of Bern, University Hospitals of the Ruhr-University of Bochum, University of Debrecen, University of Milan, Nordland Hospital Trust, University of Pisa, University of Ljubljana, Ljubljana University Medical Centre, Aristotle University of Thessaloniki, National and Kapodistrian University of Athens, University of Zagreb, Centre for Arctic Gas Hydrate, Environment and Climate, UiT The Arctic University of Norway, University of Ferrara, Medizinische Hochschule Brandenburg Theodor Fontane, University Hospital Centre Zagreb, Institut Pasteur, Gentofte Hospital, Université Libre de Bruxelles, Institute of Infection and Immunity, St. Vincent's University Hospital, Hospital Universitario Virgen de las Nieves, Arcispedale Sant'Anna, Hidradenitis Suppurativa Foundation, Klinikum Darmstadt, Andreas Sygros Hospital